about
Lymph node transfer and perinodal lymphatic growth factor treatment for lymphedemaSilencing of either SR-A or CD36 reduces atherosclerosis in hyperlipidaemic mice and reveals reciprocal upregulation of these receptors.Vascular endothelial growth factor-B induces myocardium-specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1- and neuropilin receptor-1-dependent mechanisms.O5.5. SLEEP IN MAJOR PSYCHIATRIC DISORDERS: RESULTS FROM NATIONWIDE SUPER FINLAND STUDY.Growth Factor Therapy and Autologous Lymph Node Transfer in LymphedemaAntegrade in situ fenestration of aortic stent graft: in-vivo experiments using a pig modelCorrection: Neurobiological roots of psychopathySubstance Abuse and Excessive Mortality Among Forensic Psychiatric Patients: A Finnish Nationwide Cohort StudyNeurobiological roots of psychopathySex-specific transcriptional and proteomic signatures in schizophrenia
P50
Q28275801-81456D97-59AB-437D-8AE1-C483B93A2034Q39679664-B336E87C-F0DB-4528-BC5E-329C0DEB6CADQ51843697-B6464048-930B-4625-97C0-B914608BDFD2Q54917787-0D3111B6-1324-4644-8E1A-8F72C4979688Q57381931-16D6B8DF-F319-4CC0-9EA2-5CBA1442E7E5Q84575170-66C6847C-2F92-47D4-9ACE-3BD02BB899E2Q90390534-27A0ABF2-54C9-492C-9D42-1BF7AC7D322BQ90400387-C42CE757-6386-442B-880D-0F620691F02CQ92914164-FB3EDBA0-C0B7-4DAC-BDE1-4458068B6ADBQ93063718-D9886B81-5FC6-49A3-A64E-33772B303E73
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Markku T Lähteenvuo
@ast
Markku T Lähteenvuo
@en
Markku T Lähteenvuo
@es
Markku T Lähteenvuo
@nl
type
label
Markku T Lähteenvuo
@ast
Markku T Lähteenvuo
@en
Markku T Lähteenvuo
@es
Markku T Lähteenvuo
@nl
prefLabel
Markku T Lähteenvuo
@ast
Markku T Lähteenvuo
@en
Markku T Lähteenvuo
@es
Markku T Lähteenvuo
@nl
P106
P31
P496
0000-0002-7244-145X